Dr Lalchandani Labs Ltd vs Poly Medicure Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Dr Lalchandani Labs Ltd is ₹ 6.96 as of 23 Oct 15:30 . The P/E Ratio of Dr Lalchandani Labs Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Poly Medicure Ltd changed from 57.7 on March 2021 to 37.5 on March 2026 . This represents a CAGR of -6.93% over 6 years The Market Cap of Dr Lalchandani Labs Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Poly Medicure Ltd changed from ₹ 7839 crore on March 2021 to ₹ 12069 crore on March 2026 . This represents a CAGR of 7.46% over 6 years The revenue of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Poly Medicure Ltd for the Jun '26 is ₹ 560.34 crore as compare to the Mar '26 revenue of ₹ 553.98 crore. This represent the growth of 1.15% The ebitda of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Poly Medicure Ltd for the Jun '26 is ₹ 160.06 crore as compare to the Mar '26 ebitda of ₹ 129.86 crore. This represent the growth of 23.26% The net profit of Dr Lalchandani Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Poly Medicure Ltd changed from ₹ 74.04 crore to ₹ 85.27 crore over 9 quarters. This represents a CAGR of 6.48% The Dividend Payout of Dr Lalchandani Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Poly Medicure Ltd changed from 18.51 % on March 2021 to 10.56 % on March 2026 . This represents a CAGR of -8.93% over 6 years .

About Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories.
Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017.
The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Poly Medicure Ltd

Poly Medicure Limited was incorporated on March 30, 1995.
The Company is a manufacturer/producer of Medical Devices.
It manufactures and supply, in India and internationally, a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices and others. The Company's product portfolio comprises of more than 130 SKUs of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others.

FAQs for the comparison of Dr Lalchandani Labs Ltd and Poly Medicure Ltd

Which company has a larger market capitalization, Dr Lalchandani Labs Ltd or Poly Medicure Ltd?

Market cap of Dr Lalchandani Labs Ltd is 6 Cr while Market cap of Poly Medicure Ltd is 14,628 Cr

What are the key factors driving the stock performance of Dr Lalchandani Labs Ltd and Poly Medicure Ltd?

The stock performance of Dr Lalchandani Labs Ltd and Poly Medicure Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lalchandani Labs Ltd and Poly Medicure Ltd?

As of October 25, 2026, the Dr Lalchandani Labs Ltd stock price is INR ₹6.96. On the other hand, Poly Medicure Ltd stock price is INR ₹1443.2.

How do dividend payouts of Dr Lalchandani Labs Ltd and Poly Medicure Ltd compare?

To compare the dividend payouts of Dr Lalchandani Labs Ltd and Poly Medicure Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.